The pause in Johnson & Johnson’s COVID-19 vaccine trial justifies why Big Pharma isn’t eager to rush to market
October 13, 2020 at 10:37 AM EDT
Pharmaceutical companies will resist pressure from politicians such as U.S. President Donald Trump to speed up the vaccine trial and approval process.
